Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates that HIMS & HERS HEALTH INC (HIMS) receives a 75% rating based on their Small-Cap Growth Investor model, which is based on the Motley Fool strategy. The analysis highlights strengths in profit margin, relative strength, sales and EPS growth, insider holdings, cash flow from operations, and R&D, but flags concerns regarding cash and cash equivalents, the Fool Ratio, average shares outstanding, sales, and daily dollar volume. While the 75% rating suggests some interest from the strategy, it falls short of the 80% threshold typically indicating stronger conviction.

Analysis

HIMS & HERS HEALTH INC (HIMS), identified as a large-cap growth stock within the Biotechnology & Drugs industry, received a 75% rating from Validea's Small-Cap Growth Investor model, a strategy based on the Motley Fool's approach. This score indicates a moderate alignment with the model's criteria, which seeks small-cap growth stocks with robust fundamentals and strong price performance, but it falls below the 80% threshold that typically signifies more pronounced interest. HIMS demonstrated strengths by passing tests related to profit margin, relative price strength, year-over-year sales and EPS growth comparisons, insider holdings, cash flow from operations, profit margin consistency, R&D as a percentage of sales, inventory to sales, accounts receivable to sales, and its long-term debt/equity ratio. However, the company failed to meet criteria concerning its cash and cash equivalents, "The Fool Ratio" (a P/E to growth metric indicating valuation concerns), average shares outstanding, absolute sales levels, daily dollar volume, and its income tax percentage. The application of a small-cap focused model to a large-cap company like HIMS might influence the outcome of certain metrics, particularly those related to scale such as absolute sales figures or daily trading volume, which might have different benchmarks in a small-cap context.

Key Decisions for Investors

• Investors should view the 75% rating as a sign of a mixed fundamental profile under this specific growth model, warranting careful examination of the failed metrics, especially cash levels, the P/E to growth valuation, and average shares outstanding.
• Further due diligence is advisable to determine if the 'failed' criteria, such as absolute sales, daily dollar volume, and income tax percentage, represent genuine concerns for a large-cap entity or are primarily artifacts of the small-cap model's specific thresholds.
• Consider HIMS if its demonstrated strengths in areas like YoY growth, profit margins, and debt structure align with your investment thesis for growth, but remain cognizant of the sub-80% score and the flagged weaknesses, which could imply higher risk or specific areas needing improvement.